RDIF and “R-Pharm” will invest 4 billion rubles in the development of drugs for the treatment of COVID-19

The Russian direct investment Fund (RDIF) and the pharmaceutical company “R-Pharm” intend to invest at least 4 billion rubles in the expansion of production of drugs for the treatment COVID-19, as well as the development of vaccines against coronavirus infection, writes Forbes.

According to the owner of “R-Pharm” Alexey Repik, soon his company and RDIF will set up a separate legal entity. Repik did not specify how distribution of shares in the new company, saying only that it would be about “equal partnership”.

One of the areas for investment will be the production of the drug olokizumab (Ortigia), developed “R-Pharm” initially for the treatment of rheumatoid arthritis. The drug is a monoclonal antibody that blocks directly interleukin-6. Rokyzana made to the existing guidelines of the Ministry of health therapy for coronavirus infection – it can be used to prevent cytokine storm, a powerful inflammatory reaction that often occurs when COVID-19.

Also, the partners intend to invest in a vaccine against coronavirus infection developed by the National research centre of epidemiology and Microbiology. N. F. Gamalei.

Repik said that the issue of organizing production of the vaccine “R-Pharm” interacts with the center Gamalei March 2020. According to him, the vaccine will be produced in the new building of the company “R-Pharm” in Yaroslavl. Repik also said that his company is in talks according to another embodiment of the vaccine, involving foreign companies.

Leave a Reply

Your email address will not be published. Required fields are marked *


For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]